Colorectal Cancer Screening Market Growing at CAGR of 7.5% between 2022 and 2028 | Polymedco, Eiken, Sysmex Corp
SEATTLE, UNITED STATES, UNITED STATES, October 12, 2022 /EINPresswire.com/ -- Colorectal cancer, often known as colon cancer, is a type of cancer that starts in the large intestine (colon). The colon is the last stop on the digestive system. A polyp, or growth inside the colon or rectum, is typically the first sign of malignancy. Polyps should be detected and removed to avoid colorectal cancer. Rectal cancer and colon cancer are frequently grouped due to their similarities. Cancer arises when bodily cells begin to proliferate uncontrollably. Colonoscopy is a procedure used to look for polyps or cancer in the colon and rectum. A colonoscope—a flexible, lighted tube with a lens for viewing and a tool for removing tissue—is used during this test to inspect the rectum and the entire colon.
The global Colorectal Cancer Screening market generated $12,866.16 billion in 2021 and is projected to reach $21,135.40 Mn By 2028, with a CAGR of 7.5% over the forecast period (2022 – 2028).
Request More Information on this Report (Including Full TOC, Table & Figures)
https://www.coherentmarketinsights.com/insight/request-sample/5098
Market Drivers
Over the projected period, it is anticipated that the worldwide colorectal cancer screening market would develop more rapidly due to the rising incidence of the disease. Colorectal cancer ranks third in the United States for cancer-related fatalities among both men and women. The American Cancer Society projects that there will be 52,580 cancer fatalities and around 106,180 newly diagnosed cancer cases in the United States in 2022. As a result, colorectal cancer screening is becoming more and more popular in this area.
Over the course of the projected period, rising demand for colorectal cancer screening tests is anticipated to fuel market expansion. For instance, Shield, the company’s first blood-based test for the identification of early-stage colorectal cancer, was made available, according to a May 2022 announcement from Guardant Health, Inc. Adults age 45 and older who have not followed recommended screening recommendations, have no symptoms, and are at average risk for colorectal cancer should have the test.
The following Key Players are Mentioned in this Document: Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, and Clinical Genomics Technologies Pty Ltd., among others
Colorectal Cancer Screening Market: Segmentation
By Screening Tests:
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Other Screening Tests
Colorectal Cancer Screening Market: Regional Analysis
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
(*NOTE: To get customization to your liking you can ADD / REMOVE Key Players, Regions, and any other Segments as you need.)
Click the link to PDF Brochure with Latest Insights
https://www.coherentmarketinsights.com/insight/request-pdf/5098
How Covid 19 Affected the Colorectal Cancer Screening Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Impact Colorectal Cancer Screening market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations, travel bans, and quarantines, restaurants closed, all indoor/outdoor events restricted, over forty countries’ state of emergency declared, massive slowing of the supply chain, stock market volatility, falling business confidence, growing panic among the population, and uncertainty about future.
In this segment, we will give you the impact of COVID-19, how it affected the Colorectal Cancer Screening market, and how it will change the industry’s future depending on the current government, private, and public situations. Our expert analysts keep an open eye on every situation that may change the flow of the industry which will help you make the best possible decision for your enterprise.
The objective of the study is to define the Colorectal Cancer Screening market sizes of different segments and countries in previous years and to forecast the values for the next five years. The report is designed to incorporate qualified qualitative and quantitative aspects of the industry with respect to each region and country involved in the study. Furthermore, the report also caters the detailed information about crucial aspects such as drivers and restraining factors that will define the future growth of the Colorectal Cancer Screening market.
SPECIAL OFFER (Avail an Up-to 30% discount on this report )
https://www.coherentmarketinsights.com/insight/buy-now/5098
Report Coverage:
• Provides a comprehensive understanding of the Colorectal Cancer Screening market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors, and Porter’s five analysis
• Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
• Uncovers potential demands in the market
• Porter analysis identifies competitive forces within the market
• Provides information on the historical and current market size and the future potential of the market
• Provides sizes of key regional markets using yardsticks of processes, segments, products, end-user, technology, etc (as applicable)
• Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments, and merger acquisitions
Why Choose Colorectal Cancer Screening Market Report?
• Unbiased conclusions and market insights
• 24×7 customer service available to address client queries
• Highly efficient and experienced team of analysts striving to create top-quality reports
• Our reports have facilitated the growth of over 500 companies
• A systematic and methodical market research process
Enquiry before buying this premium Report
https://www.coherentmarketinsights.com/insight/talk-to-analyst/5098
About us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed to playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
☛ Contact us:
Mr. Shah
✉ sales@coherentmarketinsights.com
United States of America: 📞+1-206-701-6702
United Kingdom: 📞+44-020-8133-4027
Japan: 📞+050-5539-1737
India: 📞+91-848-285-0837
1001 4th Ave, #3200 Seattle,
WA 98154, USA
🌐 https://www.coherentmarketinsights.com
Mr.Shah
Coherent Market Insights
+1 2067016702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
